TTrialPathMatch Me to Trials
← Back to trials
RecruitingAmenorrheaOligomenorrheaPCOS (Polycystic Ovary Syndrome)

Treatment of Menstrual Cycle Alterations in Adolescents

Eligible age

14–19 yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

the aim of the present study is intended to evaluate how treatment with Myo-Inositol and Dioscorea Villosa can help improve menstrual cycle irregularities in adolescents, both with and without PCOS.

Sponsor: Lo.Li.Pharma s.r.l

You may qualify if…

  • ✓ adolescent women aged 14-19 years old, with at least 3 years passed after menarche, and oligomenorrhea or amenorrhea

You may not qualify if…

  • ✕ Primary amenorrhea.
  • ✕ Hyperandrogenism due to other factors (i.e. adrenal hyperplasia or Cushing syndrome).
  • ✕ Hyperprolactinemia or overt hypothyroidism (TSH ≥4).
  • ✕ Other hormonal alterations.
  • ✕ Ongoing hormonal therapies, including OCPs, six months before enrollment.
  • ✕ Ongoing pharmacological therapies.
  • ✕ Ongoing use of myo-Inositol supplement or other source of myo-Inositol, or Dioscorea villosa, six months before enrollment.

Where it's recruiting

Georgia

Tbilisi

Source: ClinicalTrials.gov · NCT06800170 · last updated 2026-01-06

Treatment of Menstrual Cycle Alterations in Adolescents · TrialPath